缓解 2 型糖尿病:在阿育吠陀医学中,以Biophytum sensitivum (L.) DC.和Mimosa pudica L.替代决明子的科学验证

Abdul Rahim Muhammed Jasim , Sivaji Yuvaranjani , Alaganandam Kumaran
{"title":"缓解 2 型糖尿病:在阿育吠陀医学中,以Biophytum sensitivum (L.) DC.和Mimosa pudica L.替代决明子的科学验证","authors":"Abdul Rahim Muhammed Jasim ,&nbsp;Sivaji Yuvaranjani ,&nbsp;Alaganandam Kumaran","doi":"10.1016/j.prenap.2024.100091","DOIUrl":null,"url":null,"abstract":"<div><div>The Ayurvedic concept of 'pratinidhi dravya' (substitute drugs) offers a systematic approach to replaces scarce ingredients in traditional formulations with botanically or pharmacologically similar alternatives. This practice aims to maintain therapeutic efficacy and safety while preventing adulteration. However, scientific validation of these substitutes is essential. This study investigates the substitution of the rare species <em>Cassia mimosoides</em> L. (CM) with two more readily available species recommended in Ayurveda: <em>Biophytum sensitivum</em> (L.) DC. (BS) and <em>Mimosa pudica</em> L. (MP). The research focuses on their potential use in the popular antidiabetic Ayurvedic medicine Katakakhadiradi Kashayam, specifically examining their antioxidant and antidiabetic properties. Our findings revealed that the substituted species, BS and MP, exhibit a remarkable richness in phenolic and flavonoid content compared to the species CM, indicating their potent antioxidant capabilities (IC<sub>50</sub> values: CM: 19.55 μg/ml, BS: 60.38 μg/ml, MP: 39.49 μg/ml). LC-MS/MS profiling and quantification indicate a significant amount of different pharmacologically active polyphenols in the three species. Among the identified compounds, orientin (CM-EA: 44.362 mg/kg, BS-EA: 20.528 mg/kg, MP-EA: 34.094 mg/kg) and isoorientin (CM-EA: 85.022 mg/kg, BS-EA: 25.168 mg/kg, MP-EA: 45.035 mg/kg) were the major compounds present in substantial quantity in all three species. Additionally, shikimic acid and chlorogenic acid were present in higher concentrations in the BS-EA and MP-EA extracts. Furthermore, these species demonstrated significant activity against α-glucosidase in various solvent extracts, with IC<sub>50</sub> values of 16.44 μg/ml for CM, 56.65 μg/ml for MP, and 69.25 μg/ml for BS, suggesting their promising role in managing diabetes mellitus. These findings support the efficacy of BS and MP as substitutes for CM in managing diabetes and oxidative stress, emphasizing the importance of scientific validation in herbal medicine substitution and adulteration prevention.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"5 ","pages":"Article 100091"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mitigating type 2 diabetes: Scientific validation of Biophytum sensitivum (L.) DC. and Mimosa pudica L. as substitutes for Cassia mimosoides L. in ayurvedic medicine\",\"authors\":\"Abdul Rahim Muhammed Jasim ,&nbsp;Sivaji Yuvaranjani ,&nbsp;Alaganandam Kumaran\",\"doi\":\"10.1016/j.prenap.2024.100091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The Ayurvedic concept of 'pratinidhi dravya' (substitute drugs) offers a systematic approach to replaces scarce ingredients in traditional formulations with botanically or pharmacologically similar alternatives. This practice aims to maintain therapeutic efficacy and safety while preventing adulteration. However, scientific validation of these substitutes is essential. This study investigates the substitution of the rare species <em>Cassia mimosoides</em> L. (CM) with two more readily available species recommended in Ayurveda: <em>Biophytum sensitivum</em> (L.) DC. (BS) and <em>Mimosa pudica</em> L. (MP). The research focuses on their potential use in the popular antidiabetic Ayurvedic medicine Katakakhadiradi Kashayam, specifically examining their antioxidant and antidiabetic properties. Our findings revealed that the substituted species, BS and MP, exhibit a remarkable richness in phenolic and flavonoid content compared to the species CM, indicating their potent antioxidant capabilities (IC<sub>50</sub> values: CM: 19.55 μg/ml, BS: 60.38 μg/ml, MP: 39.49 μg/ml). LC-MS/MS profiling and quantification indicate a significant amount of different pharmacologically active polyphenols in the three species. Among the identified compounds, orientin (CM-EA: 44.362 mg/kg, BS-EA: 20.528 mg/kg, MP-EA: 34.094 mg/kg) and isoorientin (CM-EA: 85.022 mg/kg, BS-EA: 25.168 mg/kg, MP-EA: 45.035 mg/kg) were the major compounds present in substantial quantity in all three species. Additionally, shikimic acid and chlorogenic acid were present in higher concentrations in the BS-EA and MP-EA extracts. Furthermore, these species demonstrated significant activity against α-glucosidase in various solvent extracts, with IC<sub>50</sub> values of 16.44 μg/ml for CM, 56.65 μg/ml for MP, and 69.25 μg/ml for BS, suggesting their promising role in managing diabetes mellitus. These findings support the efficacy of BS and MP as substitutes for CM in managing diabetes and oxidative stress, emphasizing the importance of scientific validation in herbal medicine substitution and adulteration prevention.</div></div>\",\"PeriodicalId\":101014,\"journal\":{\"name\":\"Pharmacological Research - Natural Products\",\"volume\":\"5 \",\"pages\":\"Article 100091\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacological Research - Natural Products\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S295019972400079X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S295019972400079X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

阿育吠陀的 "pratinidhi dravya"(替代药物)概念提供了一种系统方法,用植物学或药理学上相似的替代品取代传统配方中的稀缺成分。这种做法旨在保持疗效和安全性,同时防止掺假。然而,对这些替代品进行科学验证至关重要。本研究调查了用阿育吠陀中推荐的两种更易获得的物种替代稀有物种决明子(CM)的情况:Biophytum sensitivum (L.) DC.(BS) 和 Mimosa pudica L. (MP)。研究的重点是它们在阿育吠陀常用的抗糖尿病药物 Katakakhadiradi Kashayam 中的潜在用途,特别是检查它们的抗氧化和抗糖尿病特性。我们的研究结果表明,与 CM 相比,BS 和 MP 的酚类和类黄酮含量显著丰富,这表明它们具有很强的抗氧化能力(IC50 值:CM:19.55 μg/ml;BS:60.38 μg/ml;MP:39.49 μg/ml)。LC-MS/MS 分析和定量结果表明,这三种植物中含有大量不同药理活性的多酚类化合物。在已鉴定的化合物中,荭草苷(CM-EA:44.362 毫克/千克,BS-EA:20.528 毫克/千克,MP-EA:34.094 毫克/千克)和异荭草苷(CM-EA:85.022 毫克/千克,BS-EA:25.168 毫克/千克,MP-EA:45.035 毫克/千克)是这三种植物中大量存在的主要化合物。此外,莽草酸和绿原酸在 BS-EA 和 MP-EA 提取物中含量较高。此外,在各种溶剂提取物中,这些物种对α-葡萄糖苷酶具有明显的活性,CM 的 IC50 值为 16.44 μg/ml,MP 为 56.65 μg/ml,BS 为 69.25 μg/ml,这表明它们在控制糖尿病方面具有良好的作用。这些研究结果支持 BS 和 MP 作为中药替代品在控制糖尿病和氧化应激方面的功效,强调了科学验证在中药替代和防止掺假方面的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mitigating type 2 diabetes: Scientific validation of Biophytum sensitivum (L.) DC. and Mimosa pudica L. as substitutes for Cassia mimosoides L. in ayurvedic medicine
The Ayurvedic concept of 'pratinidhi dravya' (substitute drugs) offers a systematic approach to replaces scarce ingredients in traditional formulations with botanically or pharmacologically similar alternatives. This practice aims to maintain therapeutic efficacy and safety while preventing adulteration. However, scientific validation of these substitutes is essential. This study investigates the substitution of the rare species Cassia mimosoides L. (CM) with two more readily available species recommended in Ayurveda: Biophytum sensitivum (L.) DC. (BS) and Mimosa pudica L. (MP). The research focuses on their potential use in the popular antidiabetic Ayurvedic medicine Katakakhadiradi Kashayam, specifically examining their antioxidant and antidiabetic properties. Our findings revealed that the substituted species, BS and MP, exhibit a remarkable richness in phenolic and flavonoid content compared to the species CM, indicating their potent antioxidant capabilities (IC50 values: CM: 19.55 μg/ml, BS: 60.38 μg/ml, MP: 39.49 μg/ml). LC-MS/MS profiling and quantification indicate a significant amount of different pharmacologically active polyphenols in the three species. Among the identified compounds, orientin (CM-EA: 44.362 mg/kg, BS-EA: 20.528 mg/kg, MP-EA: 34.094 mg/kg) and isoorientin (CM-EA: 85.022 mg/kg, BS-EA: 25.168 mg/kg, MP-EA: 45.035 mg/kg) were the major compounds present in substantial quantity in all three species. Additionally, shikimic acid and chlorogenic acid were present in higher concentrations in the BS-EA and MP-EA extracts. Furthermore, these species demonstrated significant activity against α-glucosidase in various solvent extracts, with IC50 values of 16.44 μg/ml for CM, 56.65 μg/ml for MP, and 69.25 μg/ml for BS, suggesting their promising role in managing diabetes mellitus. These findings support the efficacy of BS and MP as substitutes for CM in managing diabetes and oxidative stress, emphasizing the importance of scientific validation in herbal medicine substitution and adulteration prevention.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信